Pfizer Still Wants AstraZeneca After Rejected Bid

Pfizer Still Wants AstraZeneca After Rejected Bid Play

April 28 (Bloomberg) -- Pfizer proposed buying AstraZeneca for about 58.8 billion pounds ($98.7 billion) in what would rank as the biggest-ever takeover of a U.K. company and continues to be interested in a deal after being spurned. Skybridge Capital Senior Portfolio Manager Troy Gayeski and Bloomberg’s Jeff McCracken speak on Bloomberg Television's "Bloomberg Surveillance." (Source: Bloomberg)

  • On Air Now

    Market Makers Watch Now

  • Next

    Money Clip

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus